Top Markets
#1 Black Phoenix Black Phoenix +195.09%
#2 Islamic Coin Islamic Coin +158.04%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +36.39%
#5 Acurast Acurast +29.10%
#6 Cryptopia Cryptopia +21.79%
#7 BasedHype BasedHype +20.91%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +17.30%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
#10 Playnance Playnance +14.07%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Rank in Stocks #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Share Price
$0.00156481
Last synced: 2024-06-05
Market Cap
$17.03K
Change (1 day)
2.11%
Change (1 year)
0.00%
Country
GB
Trade Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Category

Healthcare
Earnings for Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Earnings in 2026 TTM: 0
According to Oxford Cannabinoid Technologies Holdings Plc latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Oxford Cannabinoid Technologies Holdings Plc from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE